| Literature DB >> 25400171 |
Bang-Zhen Pan, Mao-Sheng Chen, Jun Ni, Zeng-Fu Xu1.
Abstract
BACKGROUND: Jatropha curcas, whose seed content is approximately 30-40% oil, is an ideal feedstock for producing biodiesel and bio-jet fuels. However, Jatropha plants have a low number of female flowers, which results in low seed yield that cannot meet the needs of the biofuel industry. Thus, increasing the number of female flowers is critical for the improvement of Jatropha seed yield. Our previous findings showed that cytokinin treatment can increase the flower number and female to male ratio and also induce bisexual flowers in Jatropha. The mechanisms underlying the influence of cytokinin on Jatropha flower development and sex determination, however, have not been clarified. <br> RESULTS: This study examined the transcriptional levels of genes involved in the response to cytokinin in Jatropha inflorescence meristems at different time points after cytokinin treatment by 454 sequencing, which gave rise to a total of 294.6 Mb of transcript sequences. Up-regulated and down-regulated annotated and novel genes were identified, and the expression levels of the genes of interest were confirmed by qRT-PCR. The identified transcripts include those encoding genes involved in the biosynthesis, metabolism, and signaling of cytokinin and other plant hormones, flower development and cell division, which may be related to phenotypic changes of Jatropha in response to cytokinin treatment. Our analysis indicated that Jatropha orthologs of the floral organ identity genes known as ABCE model genes, JcAP1,2, JcPI, JcAG, and JcSEP1,2,3, were all significantly repressed, with an exception of one B-function gene JcAP3 that was shown to be up-regulated by BA treatment, indicating different mechanisms to be involved in the floral organ development of unisexual flowers of Jatropha and bisexual flowers of Arabidopsis. Several cell division-related genes, including JcCycA3;2, JcCycD3;1, JcCycD3;2 and JcTSO1, were up-regulated, which may contribute to the increased flower number after cytokinin treatment. <br> CONCLUSIONS: This study presents the first report of global expression patterns of cytokinin-regulated transcripts in Jatropha inflorescence meristems. This report laid the foundation for further mechanistic studies on Jatropha and other non-model plants responding to cytokinin. Moreover, the identification of functional candidate genes will be useful for generating superior varieties of high-yielding transgenic Jatropha.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25400171 PMCID: PMC4246439 DOI: 10.1186/1471-2164-15-974
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Figure 1Effects of BA on flower development and fruiting of . Inflorescence (A, B) and infructescence (C, D) from control plants (A, C) and BA-treated plants (B, D). Female flowers are marked with red arrows in A and B.
Characteristics of raw data and assembly summary
| 0 HAT | 2 HAT | 6 HAT | 24 HAT | |
|---|---|---|---|---|
| Raw sequencing reads | 200,913 | 201,598 | 248,674 | 188,020 |
| Total number of raw read | 839,205 | |||
| Average length of raw read | 351 bp | |||
| High quality reads | 182,722 | 172,682 | 181,699 | 166,652 |
| Total number of high quality read | 703,755 | |||
| Average length of high quality read | 364 bp | |||
| Length range of high quality read | 100 bp - 790 bp | |||
| Total number of singleton | 58,920 | |||
| Average length of singleton | 334 bp | |||
| Total number of contig | 23,591 | |||
| Assembled reads (of total number of high quality read) | 644,835 (91.63%) | |||
| Average length of contig | 740 bp | |||
Figure 2Distribution of the number of reads per contig and the length distribution of the contigs and singletons. (A) Distribution of the sequences in the contigs; (B) Length distribution of the contigs; (C) Length distribution of the singletons.
Transcriptome annotation summary
| Contigs | Singletons | Total unigenes | |
|---|---|---|---|
| Number | 23,591 | 58,920 | 82,511 |
| Predicted CDS | 23,576 | 58,160 | 81,736 |
| Average CDS length | 740 bp | 549 bp | 604 bp |
| Maximum CDS length | 1,230 bp | 564 bp | 1230 bp |
| CDS with known function | 18,429 | 28,356 | 46,785 |
| CDS with KOG assignment | 10,727 | 12,864 | 23,591 |
| CDS with GO classification | 8,148 | 11,030 | 19,178 |
| Unigene sequences mapped to | 18,504 | 28,848 | 47,352 |
CDS: coding sequence; KOG: eukaryotic orthologous groups; GO: gene ontology.
Figure 3Clustering of differentially expressed genes in the transcriptome of inflorescence meristems treated with BA. N is the number of transcripts found in each cluster. Cluster I and II contain cytokinin-repressed or induced genes at all three time points, respectively; Cluster III, V and VII contain cytokinin-induced genes at T, T +4 H and T +22 H, respectively; Cluster IV, VI and VIII contain cytokinin-repressed genes at T, T +4 H and T +22 H, respectively. A number of differentially expressed genes were included in more than one cluster according to their expression profiles. The y-axis represents the normalized expression value. The expression value of each gene was Z-score (mean centered, with standard deviations as the unit, p <0.05). T: BA treatment for 2 hours, T +4 H: 4 hours post BA treatment, T +22 H: 22 hours post BA treatment.
GO enrichment analysis of differential transcripts in eight clusters (p <0.05)
| Cluster | Biological processes | Molecular function |
|---|---|---|
| I | axon extension involved in development | __ |
| developmental cell growth | ||
| ubiquitin-dependent protein catabolic process | ||
| DNA replication | ||
| carbohydrate metabolic process | ||
| II | cellular aromatic compound metabolic process | receptor activity |
| glutamine family amino acid metabolic process | molecular transducer activity | |
| nitrogen compound biosynthetic process | signal transducer activity | |
| positive regulation of signal transduction | ||
| sensory perception of light stimulus | ||
| III | DNA replication | base pairing with mRNA |
| carboxylic acid metabolic process | sodium ion binding | |
| cellular ketone metabolic process | RNA binding | |
| fertilization | triplet codon-amino acid adaptor activity | |
| long-chain fatty acid metabolic process | ||
| IV | cellular response to hormone stimulus | receptor activity |
| hormone-mediated signaling | signal transducer activity | |
| negative regulation of cell death | transmembrane receptor activity | |
| regulation of cell activation | ferric iron binding | |
| fatty acid binding | ||
| V | transcription initiation | threonine-type endopeptidase activity |
| female pregnancy | sodium:hydrogen antiporter activity | |
| regulation of cell size | histone acetyltransferase activity | |
| regulation of hormone secretion | lysine N-acetyltransferase activity | |
| calcium ion homeostasis | monovalent cation:hydrogen | |
| antiporter activity | ||
| VI | carboxylic acid catabolic process | hormone binding |
| cell death | transmembrane receptor activity | |
| gene silencing by RNA | fatty acid transporter activity | |
| glucose catabolic process | copper ion binding | |
| glycolysis | signal transducer activity | |
| positive regulation of signal transduction | ||
| VII | translational initiation in response to stress | translation regulator activity |
| negative regulation of translation | protein transporter activity | |
| glutathione metabolic process | metallopeptidase activity | |
| antigen processing and presentation of exogenous antigen | translation initiation factor binding | |
| peptidase activity | ||
| VIII | arginine metabolic process | cadmium ion binding |
| cellular aromatic compound metabolic process | hormone binding | |
| circadian rhythm | receptor activity | |
| nitrogen compound biosynthetic process | signal transducer activity | |
| positive regulation of cell differentiation | ||
| signal transduction |
KEGG pathway enrichment analysis of differentially expressed transcripts in eight clusters (p <0.05)
| Cluster | KEGG pathway | p-value |
|---|---|---|
| I | Apoptosis | 0.002 |
| Steroid hormone biosynthesis | 0.021 | |
| Arginine and proline metabolism | 0.029 | |
| Alanine, aspartate and glutamate metabolism | 0.03 | |
| II | Cell cycle | 0.059 |
| DNA replication | 0.097 | |
| III | -- | -- |
| IV | Pyruvate metabolism | 0.017 |
| Apoptosis | 0.018 | |
| V | Proteasome | 0.0073 |
| Pyrimidine metabolism | 0.038 | |
| VI | Apoptosis | 0.0092 |
| Purine metabolism | 0.014 | |
| Endocytosis | 0.019 | |
| Pyruvate metabolism | 0.021 | |
| Citrate cycle (TCA cycle) | 0.026 | |
| Calcium signaling pathway | 0.037 | |
| VII | DNA replication | 0.041 |
| Steroid hormone biosynthesis | 0.047 | |
| VIII | Metabolism of xenobiotics by cytochrome P450 | 0.027 |
| Apoptosis | 0.036 |
Figure 4Expression profiles of cytokinin biosynthesis- and metabolism-related genes and two-component elements following BA treatment. Colors indicate the expression values scaled to the standard deviations and centered at the control intensity level (Z-score). Red indicates increased expression and green indicates decreased expression relative to the control condition. Gene expression at time points labeled with an asterisk on the map showed significantly differential expression between treated and control inflorescence meristems (p <0.05), whereas the remaining genes were considered to not respond to BA treatment (p >0.05).
Figure 5Quantification of the expression of genes involved in cytokinin and other phytohormone signaling by qRT-PCR. Results are shown as the relative expression of genes at different time points before and after BA treatment. Values are means ± standard deviations (n =3). *Statistically significant at the 5% level, **Statistically significant at the 1% level.
Figure 6Regulation of other phytohormone signaling genes following BA treatment revealed by DEGseq analysis of the 454 transcripts. The colors indicate the expression values scaled to the standard deviations and centered at the control intensity level (Z-score). Red indicates increased expression and green indicates decreased expression relative to the control condition. Gene expression at time points labeled with an asterisk on the map showed differential expression between treated and control inflorescence meristems (p <0.05), whereas the remainder were considered to not respond to BA treatment (p >0.05).
Figure 7Expression profiles of genes involved in flower development. (A) Expression profiles of genes involved in flower development obtained by the DEGseq analysis of the 454 transcripts. The colors indicate the expression values scaled to the standard deviations and are centered at the control intensity level (Z-score). Red indicates increased expression and green indicates decreased expression relative to the control condition. Gene expression at time points labeled with an asterisk on the map showed differential expression between the treated and control inflorescence meristems (p <0.05), whereas the remaining genes were considered to not respond to BA treatment (p >0.05). (B) Quantification of gene expression by qRT-PCR. Results are shown as the relative expression of genes at different time points before and after BA treatment. Values are means ± standard deviations (n =3). **Statistically significant at the 1% level.
Figure 8Expression profiles of genes involved in cell division. (A) Expression profiles of genes involved in cell division obtained by DEGseq analysis of the 454 transcripts. The colors indicate the expression values scaled to the standard deviations and are centered at the control intensity level (Z-score). Red indicates increased expression and green indicates decreased expression relative to the control condition. Gene expression at time points labeled with an asterisk on the map showed differential expression between treated and control inflorescences (p <0.05). (B) Quantification of gene expression by qRT-PCR. Results are shown as the relative expression of genes at different time points before and after BA treatment. Values are means ± standard deviations (n =3). *Statistically significant at the 5% level, **Statistically significant at the 1% level.
Figure 9BA treatment enhanced inflorescence branching of . (A) Branching of control inflorescence. (B) Branching of BA-treated inflorescence. (C) Diagram of branching of control inflorescence. (D) Diagram of branching of BA-treated inflorescence. To clearly show the pattern of inflorescence branching, the flowers in (A) and (B) were removed. The numbers (1–5) on the branches in (C) and (D) represent different orders of branching. represents a female flower; represents a male flower.